Rafal Peksa
Overview
Explore the profile of Rafal Peksa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kunc M, Skrzypkowska P, Peksa R, Biernat W
Clin Exp Metastasis
. 2025 Jan;
42(2):14.
PMID: 39890663
Tumor-to-tumor metastasis is an exceedingly rare phenomenon where secondary deposits of a tumor develops in another one. Our systematic review and meta-analysis aims to uncover and analyze reported cases to...
2.
Michcik A, Jopek M, Peksa R, Choma P, Garbacewicz L, Polcyn A, et al.
Biomedicines
. 2025 Jan;
12(12.
PMID: 39767712
Background: An adequate OSCC macroscopic resection margin (MRM) is essential for effective treatment. This study analyzed the effects of formalin fixation (FF) on the MRM. Material And Methods: A total...
3.
Michcik A, Jopek M, Peksa R, Choma P, Garbacewicz L, Polcyn A, et al.
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594716
The histopathological assessment is critical in the comprehensive treatment process for patients diagnosed with oral squamous cell carcinoma (OSCC). A detailed and precise specimen characterization is essential to facilitate effective...
4.
Marjanski T, Chmielecki M, Klein-Awerjanow K, Cytawa W, Ciepialowska P, Bilyk A, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518718
Non-small cell lung cancer (NSCLC) is the leading cause of death from malignancies, and surgical resection is the most effective form of treatment. Coronary artery disease (CAD) is a common...
5.
Peksa R, Sharma S, Kunc M, Popeda M, Qu L, Frankiewicz M, et al.
Contemp Oncol (Pozn)
. 2024 Nov;
28(3):253-259.
PMID: 39512528
Introduction: In clear cell renal cell carcinoma (ccRCC), intravascular extension often results in neoplastic thrombus formation, impacting patient outcomes. Material And Methods: We assessed P-selectin glycoprotein ligand-1 (PSGL-1) expression in...
6.
Andreou M, Jakalski M, Duzowska K, Filipowicz N, Kostecka A, Davies H, et al.
Int J Cancer
. 2024 Jun;
155(9):1616-1628.
PMID: 38850108
Despite advances in early detection and treatment strategies, breast cancer recurrence and mortality remain a significant health issue. Recent insights suggest the prognostic potential of microscopically healthy mammary gland, in...
7.
Ciarka A, Kunc M, Popeda M, Lacko A, Radecka B, Braun M, et al.
Contemp Oncol (Pozn)
. 2024 May;
28(1):75-83.
PMID: 38800535
Introduction: This study aimed to evaluate the impact of tumour-infiltrating lymphocytes (TILs) on the expression of immune-related genes and prognosis in single hormone receptor-positive breast cancer. Material and methods: Tumour-infiltrating...
8.
Ciarka A, Piatek M, Peksa R, Kunc M, Senkus E
Biomedicines
. 2024 Apr;
12(4).
PMID: 38672117
Tumor-infiltrating lymphocytes (TILs) are pivotal in the immune response against breast cancer (BC), with their prognostic and predictive significance varying across BC subtypes. In triple-negative BC (TNBC), higher TIL levels...
9.
Skowronek F, Ciarka A, Lyzinska W, Piatek M, Peksa R, Kunc M
Pol Arch Intern Med
. 2024 Apr;
134(7-8).
PMID: 38661583
No abstract available.
10.
Wojcik M, Juhas U, Mohammadi E, Mattisson J, Drezek-Chyla K, Rychlicka-Buniowska E, et al.
Sci Rep
. 2024 Apr;
14(1):9458.
PMID: 38658633
Male sex is a risk factor for colorectal cancer (CRC) with higher illness burden and earlier onset. Thus, we hypothesized that loss of chromosome Y (LOY) in the tumor micro-environment...